Unverified50% confidenceFactExact time
The two parties to the acquisition will build on Rosalind—AI models and tools for life sciences research—to further streamline drug development operations.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/21/2026
First Seen
Valid until: 1/19/2027
Sources
Related Entities
Related Claims
UnverifiedRosalind is a suite of AI models and tools for life sciences research.64% similarUnverified专为生命科学设计的基础模型如ESM-2、BioMedLM等已相继出现，能够处理基因组序列、药物分子结构等专业数据59% similarUnverifiedThe Double Diamond model divides the innovation process into two phases: discovering the right problem and discovering the right solution.58% similarUnverifiedThe Bayesian decision theory framework naturally supports extension to more than two actions and can be used to model cost-sensitive decisions involving actions such as accept, repair, acquire more evidence, escalate to a human, and reject.57% similarUnverifiedIsomorphic Labs采用从物理第一性原理出发的结构引导药物设计方法论，区别于纯统计学习方法57% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1078753API
curl https://kongchang.com/api/v1/knowledge/claims/1078753MCP
get_claim(id=1078753)